The largest clinical trial for cariporide found no significant adverse effects of cariporide on patients (see Phase III: GUARDIAN Trial).<ref name=":2" /> However, a later clinical trial found dose-dependent increases in mortality for patients using cariporide post-CABG (see Phase III: EXPEDITION Trial).<ref name=":4" />

 

